Ronald C. Griffith
Geen lopende functies
Profiel
Ronald C.
Griffith has been Chief Scientific Officer of Genelabs Technologies, Inc. since February 2006.
Previously, he had served as Vice President of Research for Genelabs Technologies since December 2001.
From May 2001 to December 2001, Dr. Griffith was Vice President of Medicinal Chemistry with Isis Pharmaceuticals Corp.
From February 2000 to May 2001, he was Vice President of Chemistry at X-Ceptor Therapeutics.
Prior to that, Dr. Griffith was Director of Chemical Sciences at Tanabe Research Laboratories USA from 1997 to 2000.
He received a BS from Alfred University, a PhD in Organic Chemistry from Syracuse University and was a post-doctoral fellow at California Institute of Technology.
Eerdere bekende functies van Ronald C. Griffith
| Bedrijven | Functie | Einde |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2001 |
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Corporate Officer/Principal | 01-05-2001 |
Tanabe Research Laboratories U.S.A., Inc.
 Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The private company is based in San Diego, CA. | Corporate Officer/Principal | 01-01-2000 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Ronald C. Griffith
| Syracuse University | Doctorate Degree |
| Alfred University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Commercial Services |
Tanabe Research Laboratories U.S.A., Inc.
Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The private company is based in San Diego, CA. | Health Technology |
